NCT01943305
The Role of Pre-existing Cross-reactive Antibodies in Determining the Efficacy of Vaccination in Humans Not Available 2 completed NCT02880865
Immunogenicity and Safety of Japanese Encephalitis Vaccine When Given With Measles-Mumps-Rubella (MMR) Vaccine prevention 4 completed NCT02514746
Long-term Immunogenicity After Receipt of JE Vaccine and Antibody Response and Safety to a Booster Dose prevention 4 completed NCT06674837
Diagnostics and Surveillance of Acute Meningo-encephalitis Among Children in Cambodia with a Focus on Japanese Encephalitis Virus No drug interventions Not Available Not Available not_yet_recruiting NCT06331702
Immunogenicity of Japanese Encephalitis Vaccine Co-administered with Measles-Mumps-Rubella Vaccine (MMR) prevention 4 active_not_recruiting NCT00621764
Immunogenicity and Safety of ChimeriVax™ Japanese Encephalitis Vaccine in Thai Toddlers and Children prevention 2 completed NCT00463684
Live Attenuated Japanese Encephalitis (JE) Vaccine Coadministered With Measles Vaccine in Infants 9 Months of Age prevention 4 completed NCT01188343
Study of Japanese Encephalitis Chimeric Virus Vaccine Given With Measles-Mumps-Rubella Vaccine in Taiwanese Toddlers prevention 3 completed NCT01466387
A Phase 3b, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of Select Travel Vaccines When Administered Concomitantly With MenACWY in Adults prevention 3 completed NCT00314145
A Safety and Efficacy Study of Two Japanese Encephalitis Vaccines ChimeriVax™-JE and JE-VAX prevention 3 completed NCT01190228
Study of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children Previously Immunized With JE-CV prevention 3 completed NCT00596271
Concomitant Vaccination With the Japanese Encephalitis Vaccine IC51 and HARVIX® 1440 prevention 3 completed NCT00595309
Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51 prevention 3 completed NCT00605085
Safety and Tolerability of the Japanese Encephalitis Vaccine IC51 prevention 3 completed NCT02602652
Immunogenicity of a JE-CV as a Booster Dose After a Primary Vaccination With SA14-14-2 Vaccine No drug interventions prevention Not Available completed NCT00595270
Long Term Persistence and Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51 prevention 3 completed NCT01150942
Clinical Trial to Assess the Immunogenicity and Safety of the Vero Cell-derived JE Vaccine in Korea No drug interventions prevention 3 completed NCT04817917
Seroprevalence of Neutralizing Antibodies Against Japanese Encephalitis Virus Among 6 Years Old Children With 5 Different Immunization Strategies in Zhejiang Province prevention 4 unknown_status NCT00981630
Study of Live Attenuated ChimeriVax™-Japanese Encephalitis Vaccine No drug interventions prevention 2 completed NCT02492165
Study of a Single Primary Dose Live Attenuated Japanese Encephalitis Chimeric Virus Vaccine (IMOJEV®) in Healthy Subjects prevention 3 completed NCT01567865
Lot-to-lot Consistency Trial of Japanese Encephalitis Live Attenuated SA 14-14-2 Vaccine No drug interventions prevention 4 completed NCT06372665
Safety Observation of the Japanese Encephalitis Vaccine Given With a Primary Immunization No drug interventions Not Available Not Available recruiting NCT01559831
Immune Response in IXIARO Batch JEV09L37 Recipients Before and After Revaccination Not Available 1 withdrawn NCT01815073
Immunogenicity and Safety of Live Attenuated Varicella Vaccine Combined With Live Attenuated JE Vaccine prevention 4 completed NCT01386827
Ixiaro as Booster After Mouse-brain Derived Vaccines for Japanese Encephalitis prevention 3 completed NCT00463476
Boosterability of Live Attenuated Japanese Encephalitis (JE) Vaccine in Children Who Have Previously Received Inactivated JE Vaccine No drug interventions prevention 4 completed NCT00319592
A Safety and Efficacy Study of Two Japanese Encephalitis Vaccines ChimeriVaxTM-JE and JE-VAX prevention 2 completed NCT02532569
Long-term Immunogenicity and Safety of Fourth Administration of Boryung Cell-Culture Japanese Encephalitis Vaccineinj prevention 4 completed NCT01396512
Study of a Live Attenuated Japanese Encephalitis Chimeric Virus Vaccine (IMOJEV™) Compared to CD.JEVAX™ in Toddlers prevention 3 completed NCT01954810
Antibody Response of a Boosted Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children prevention 4 unknown_status NCT00604708
Immunogenicity Study of the Japanese Encephalitis Vaccine IC51 prevention 3 completed NCT00595790
Rapid Immunization Study of the Japanese Encephalitis Vaccine IC51 prevention 3 completed NCT00596102
Longterm Immunogenicity of the Japanese Encephalitis Vaccine IC51 No drug interventions Not Available Not Available completed NCT00938379
Clinical Evaluation of Insect Repellent and Insecticide Treated Nets in Lao PDR prevention 3 unknown_status NCT01246479
Long Term Immunity and Safety Following Vaccination With the JEV IC51 (IXIARO®, JESPECT®) in Pediatric Population In Non Endemic Countries. Uncontrolled, Ph3 FU-Study other 3 completed NCT02643433
Immunogenicity of Co-administration of Measles and Japanese Encephalitis Vaccines prevention 4 completed NCT02816554
Safety and Immunogenicity of JECEVAX in Young Children No drug interventions prevention 2 completed NCT05568953
An Experimental Medicine Decipher of a Minimum Correlate of Cellular Immunity basic_science 2 recruiting NCT01856205
Safety and Efficacy Study of Intravenous Immunoglobulin to Treat Japanese Encephalitis treatment 2 completed NCT03920111
Flavivirus Cross-priming Potential of IMOJEV diagnostic Not Available completed NCT01001988
Long-term Follow-up of Immunogenicity of a Single Dose of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Toddlers No drug interventions prevention 3 completed NCT01092507
A Study of Japanese Encephalitis Chimeric Virus Vaccine Compared With SA14-14-2 Vaccine in Infants and Toddlers prevention 3 completed NCT00982137
Study of Live Attenuated Japanese Encephalitis Vaccine (ChimeriVax™-JE) and Yellow Fever Vaccine (STAMARIL®) prevention 2 completed NCT00314132
Safety Study of ChimeriVax™-JE Vaccine to Prevent Japanese Encephalitis. prevention 3 completed NCT01656200
A Prospective, Open Label Study of Human T Cell Responses to Live Attenuated Japanese Encephalitis Vaccine SA14-14-2 basic_science 4 completed NCT00441259
Safety and Efficacy Study of ChimeriVax™-JE and JE Inactivated Mouse Brain Vaccine in Children of Descending Age No drug interventions prevention 2 completed NCT00981175
A Study of ChimeriVax™-JE Live Attenuated Vaccine in Healthy Adults No drug interventions prevention 2 completed NCT03282370
Evaluate Safety and Immunogenicity of a Vero Cell-Derived JE Vaccine in 9-24 Months of Age Children in Vietnam No drug interventions prevention 3 completed NCT01158599
This is a Study to Assess the Safety and Immunogenicity of Ixiaro® (IC51) in an Elderly Population prevention 4 completed NCT00594958
Comparison of Three Batches of the Japanese Encephalitis Vaccine IC51 prevention 3 completed NCT00776230
Immunogenicity of a Commercial Batch of JEV IC51 up to 24 Months Post Filling prevention 3 completed NCT00595465
Comparison of Three Commercial Batches of the Japanese Encephalitis Vaccine IC51 No drug interventions prevention 3 completed NCT03204227
Safety of Vero Cell - Derived Inactivated Japanese Encephalitis Vaccine (JECEVAX) in Children From 9-24 Months of Age No drug interventions prevention 2 completed NCT00694460
Evalution of Immunogenicity, Safety and Booster Response of a Rabies Vaccine Administered Concomitantly With Japanese Encephalitis Vaccine in Toddlers prevention 2 completed NCT01296360
Open-label, Randomized Study in a Pediatric Population in a JEV (Japanese Encephalitis Virus)-Endemic Country prevention 3 completed NCT00735644
Study of ChimeriVax™-Japanese Encephalitis Vaccine in Toddlers in Thailand and the Philippines prevention 3 completed NCT01900444
Study of a Booster Dose of IMOJEV® One Year After Primary Immunization in Healthy Children in South Korea prevention 3 completed NCT01662440
Safety and Immunogenicity of 2 Different Vaccination Schedules of Rabies and Japanese Encephalitis Vaccines in Healthy Adult Subjects No drug interventions prevention 3 completed NCT01981967
Post-licensure Safety Study of IMOJEV® in Thailand prevention 4 completed NCT00216268
Treatment of Japanese Encephalitis treatment 2 unknown_status NCT01335412
Safety Surveillance After Immunization With IXIARO Not Available Not Available completed NCT02933710
Postmarketing Surveillance Study for IMOJEV® in Republic of Korea No drug interventions Not Available Not Available completed NCT01163123
Seroepidemiology of Japanese Encephalitis Virus Infection in Hualien, Taiwan No drug interventions Not Available Not Available unknown_status NCT01408537
Immunogenicity and Safety of Inactivated Vero Cell Derived Japanese Encephalitis Vaccine in Thai Children No drug interventions prevention 3 completed NCT00412516
Determining Long-Term Safety and Efficacy of Japanese Encephalitis Vaccine When Given With Measles Vaccine No drug interventions prevention 3 completed NCT00249769
Determining Safety and Efficacy of Japanese Encephalitis Vaccine When Given With Measles Vaccine prevention 3 completed NCT04223037
Purified Inactivated Japanese Encephalitis Vaccine prevention 3 unknown_status